Schrödinger, Inc. (SDGR)

23,97 +0,63 (+2,70%) Alla chiusura: 04:00PM EDT

Schrödinger, Inc.

1540 Broadway
24th Floor
New York, NY 10036
United States
212 295 5800
https://www.schrodinger.com

Settore/i: Healthcare
Settore: Health Information Services
Impiegati a tempo pieno: 867

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Ramy Farid Ph.D.	CEO, President & Director	1,06M	1,14M	1965
Dr. Richard A. Friesner Ph.D.	Co-Founder, Scientific Advisory Chairman and Director	465k	N/D	1953
Dr. Geoffrey Craig Porges MBBS	Executive VP & CFO	888,15k	N/D	N/D
Dr. Robert Lorne Abel Ph.D.	Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D	569,45k	N/D	1982
Dr. Karen Akinsanya Ph.D.	President of Research & Development Therapeutics	797,74k	N/D	1968
Dr. Margaret Han Dugan M.D.	Chief Medical Officer	707,46k	N/D	1957
Prof. William Goddard III	Co-Founder & Scientific Advisor	N/D	N/D	N/D
Mr. Kenneth Patrick Lorton	Executive VP, CTO & COO of Software	510,09k	395,9k	1984
Mr. Shane Brauner	Executive VP & Chief Information Officer	N/D	N/D	1978
Ms. Jaren Irene Madden	Senior Vice President of Investor Relations & Corporate Communications	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Governance aziendale

L'ISS Governance QualityScore di Schrödinger, Inc. al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 6; diritti degli azionisti: 3; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.